Prelude Therapeutics (PRLD) EBT Margin Growth (1y) (2025)
Powered by 
Analysis
Prelude Therapeutics (PRLD) EBT Margin Growth (1y) (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -392.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,565.00 |
| 10 | Prelude Therapeutics | 539.17 Mn | 258.54 Mn | - | - |